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1 INTRODUCTION  
Tissue heterogeneity is a major confounding factor in studying indi-
vidual populations that cannot be resolved directly by global profil-
ing (Hoffman, et al., 2004). Experimental solutions to mitigate tis-
sue heterogeneity are expensive, time consuming, inapplicable to 
existing data, and may alter the original gene expression patterns 
(Kuhn, et al., 2011; Shen-Orr, et al., 2010). Alternatively, various in 
silico methods perform basically a supervised deconvolution based 
on either externally-obtained constituent proportions (Shen-Orr, et 
al., 2010; Stuart, et al., 2004) or previously-acquired cell-specific 
signatures (Kuhn, et al., 2011; Lu, et al., 2003). 
In the earlier issues of this journal, a few articles have reported 
semi-supervised methods that were specifically focused on dissect-
ing two-source mixed gene expressions. Gosink et al. used (known) 
expression data from a single cell type to determine the proportion 
(and subsequently expression profile) of each cell type in a hetero-
geneous sample (Gosink, et al., 2007). This method detects the min-
imum of a proportion that provides a good estimate in noiseless or 
simulation data. Built upon this work, Clarke et al. developed a ge-
ometry-based method that provides a more accurate estimate of this 
minimum in noisy real data and can be applied in situations where 
one or multiple heterologous samples are available (Clarke, et al., 
2010). These methods assume a linear mixture of log-transformed 
expression levels that has recently been shown to be invalid (Zhong 
and Liu, 2012). Ahn et al. proposed a statistical approach for decon-
volving linearly mixed cancer transcriptomes in individual samples 
under various raw measured data scenarios (Ahn, et al., 2013). This 
practical (most likely) solution again requires prior knowledge of 
gene expression of one tissue type from multiple similar samples 
and applies various heuristics.  
Here we ask whether it is possible to deconvolute two-source 
mixed expressions (estimating both proportions and cell-specific 
profiles) from two or more heterogeneous samples without requiring 
any aforementioned prior knowledge (Wang, 2004). Supported by a 
well-grounded mathematical framework, we argue that both constit-
uent proportions and cell-specific expressions can be estimated in a 
completely unsupervised mode when cell-specific marker genes ex-
ist, which do not have to be known a priori, for each of constituent 
cell types. Fundamental to the success of our approach is a geomet-
ric exploitation of cell/condition-specific marker genes and expres-
sion non-negativity. Specifically, we show that (1) the scatter plot 
of mixed expressions is a compressed version of cell-specific ex-
pressions; (2) the resident genes on the two radii of scatter sector are 
the cell-specific marker genes; (3) the radius vectors defined by the 
cell-specific marker genes are the column vectors of the mixing ma-
trix; and (4) the rank of between-tissue differentially expressed 
genes is mixing-invariant. We demonstrate the performance of un-
supervised deconvolution on both simulation and real gene expres-
sion data, together with perspective discussions. 
2 THEORY AND METHOD 
2.1 Roadmap of unsupervised deconvolution 
We adopt the linear latent variable model of raw measured expression data 
(Zhong and Liu, 2012), given by (bold font indicates column vectors)  
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where stissue1(i) and stissue2(i) are the gene expression values for pure tissues 1-
2, and xsample1(i) and xsample2(i) are the gene expression values for heterogene-
ous samples 1-2, for genes i =1,…,n, respectively; and ajk are the mixing 
proportions with a11 + a12 = a21 + a22 (after signal normalization). We further 
adopt the concept of cell-specific marker genes (MG) (Gosink, et al., 2007; 
Kuhn, et al., 2011; Wang, 2004), i.e., genes whose expression is highly and 
exclusively enriched in a particular cell population in the context of interest, 
or mathematically s(iMG1) ≈ [αi 0]T and s(iMG2) ≈ [0 βi]T. Since raw measured 
gene expression values s are non-negative, when cell-specific marker genes 
exist for each cell type, the linear latent variable model (1) is identifiable 
using two or more mixed expressions, as we will elaborate via the following 
theorems and their formal proofs (see Fig. 1 for geometric illustration).     
Theorem 1 (Scatter compression). Suppose that pure tissue expressions are 
non-negative and x(i) = a1stissue1(i) + a2stissue2(i) where a1 and a2 are linearly 
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independent, then, the scatter plot of mixed expressions is compressed into a 
scatter sector whose two radii coincide with a1 and a2.   
Proof of theorem 1. Since a1 and a2 are linearly independent, without loss of 
generality, we assume that 
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Multiply both sides by stissue2(i) and add a11a21stissue1(i) to both sides, since raw 
measured expressions are non-negative, we have 
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Since x(i) = a1stissue1(i) + a2stissue2(i), we have  
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Using a similar strategy, we can show 
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that readily completes the proof.                                                         Q.E.D. 
Theorem 2 (Unsupervised identifiability). Suppose that pure tissue expres-
sions are non-negative and cell-specific marker genes exist for each consti-
tuting tissue type, and x(i) = a1stissue1(i) + a2stissue2(i) where a1 and a2 are lin-
early independent, then, the two radii of the scatter sector of mixed expres-
sions coincide with a1 and a2 that can be readily estimated from marker gene 
expression values with appropriate rescaling.   
Proof of theorem 2. Based on the definition of cell-specific marker genes, 
i.e., s(iMG1) = [αi 0]T and s(iMG2) = [0 βi]T, and the existence of cell-specific 
marker genes for all constituting tissue types, we have 
( ) ( )1 2MG1 MG2= , = .i ii iα βx a x a  
By the conclusion of Theorem 1, we complete the proof.                   Q.E.D.  
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Figure 1. Geometric and mathematical description of the mixing process. 
Corollary 1 (Invariance of differential expression). Suppose that pure tis-
sue expressions are non-negative and x(i) = a1stissue1(i) + a2stissue2(i) where a1 
and a2 are linearly independent, then, the rank of between-tissue differen-
tially expressed genes is mixing-invariant.    
Proof of corollary 1. Without loss of generality, we assume that   
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Since a1 and a2 are linearly independent and a12a21 < a11a22, multiply both 
sides by (a11a22 - a12a21), and add a11a21stissue1(i)stissue1(j) and a12a22stissue2(i)stis-
sue2(j) to both sides, we have 
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Simple mathematical reorganizations lead to 
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Since x(i) = a1stissue1(i) + a2stissue2(i), we complete the proof with 
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From Theorem 2, there exists a mathematical solution uniquely identify-
ing the linear latent variable model (1) based on two/more mixed expres-
sions: under a noise-free scenario, we can (in principle) directly estimate a1 
and a2 by locating the two radii that most tightly enclose the scatter sector of 
mixed expressions. Moreover, Corollary 1 allows for between-tissue differ-
ential analysis from mixed expressions without requiring deconvolution.  
2.2 Algorithm and evaluation criteria 
So far, we have described the theoretical roadmap for unsupervised de-
convolution of two-source mixed expressions. We now complete the descrip-
tion of our algorithm by considering the identification of marker genes or 
mixing matrix, and its application to data deconvolution. 
Although the mixing matrix can be estimated using only one marker gene 
per tissue type, a more accurate solution, with practical applicability, is to 
estimate a1 and a2 using multiple marker genes. Our unsupervised deconvo-
lution begins by detecting the cell-specific marker genes directly from mixed 
expressions, in which the differential analysis of gene expressions is per-
formed on all genes. Mathematically, MG is defined as an index set 
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where kmax and kmin are the maximum and minimum ratios of xsample2(i) over 
xsample1(i) across all i, respectively; and ε is a pre-fixed positive small real 
number. To obtain a reliable set of marker gene indices, some pre-processing 
steps are required, including mode/mean-based normalization and removal 
of minimally-expressed and outlier genes.  
On the basis of the expression values of detected cell-specific marker 
genes, the mixing matrix is estimated using standardized sample averages, 
( )
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where MG1 and MG2 are the index sets of marker genes for tissue types 1 
and 2, respectively; nMG1 and nMG2 are the numbers of marker genes for tissue 
types 1 and 2, respectively; and ||.|| denotes the vector norm (L1 or L2). The 
resulting â1 and â2 are then used to deconvolute the mixed expressions into 
cell-specific profiles via matrix inversion techniques.  
Unsupervised deconvolution algorithm: 
1) Normalize gene expression profile using global mean/mode; 
2) Remove minimally-expressed genes whose norm is less than a pre-
fixed positive small real number δ, and outlier genes whose norm is 
bigger than a pre-fixed positive large real number γ; 
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3) Detect the indices of cell-specific marker genes, for each of the con-
stituting tissue types, according to (2); 
4) Estimate mixing matrix according to (3), normalized to proportions; 
5) Estimate cell-specific expression profiles using mixed expressions 
and matrix inversion technique(s).    
We use four complementary evaluation criteria and known ground truth to 
assess the performance of the proposed unsupervised deconvolution method. 
To assess the accuracy of tissue proportion estimates, in addition to classic 
correlation coefficient, we adopt the E1 criterion given by 
2 2 2 2
1 1 1 1
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where pij is the ijth element of the matrix [â1 â2]-1[a1 a2] with â1 and â2 being 
the estimated column vectors of mixing matrix. Note that E1 is invariant to 
permutation or scaling and E1=0 when the estimation is perfect. To assess 
the accuracy of estimated cell-specific expression patterns, we calculate the 
correlation coefficient between the estimated expression profile and ground 
truth over ‘marker genes’ and ‘all genes’ respectively. Moreover, to assess 
the membership (and rank) match (and mismatch) between the marker genes 
detected from pure versus mixed expressions, we utilize Venn diagrams, to-
gether with Spearman’s rank correlation coefficient.   
More details on algorithm, parameter settings, and alternative schemes, 
are included in the supplementary information.         
3 EXPERIMENTAL RESULTS 
3.1 Validation on cell line expression data 
We first considered numerical mixtures of two human cell line ex-
pressions, a situation in which all factors are known and linear mix-
ture model is ideal. We reconstituted mixed expressions by multi-
plying the measured cell line expressions by the proportion of the 
tissue subset in a given heterogeneous sample (Fig. 1). We detected 
the cell-specific marker genes solely based on the reconstituted ex-
pression mixtures and accordingly obtained a highly accurate esti-
mate of the mixing matrix with E1=0.0295 (and a correlation coef-
ficient of 0.99) (Table 1). For each cell line, a comparison of the 
estimated expression profile of each type to the measured expression 
pattern in the pure cell line showed an almost perfect correlation 
with an average correlation coefficient of 0.99, indicating that we 
could accurately deconvolute the mixed expressions into constituent 
expression patterns in a completely unsupervised way.  
Table 1. Identification of linear mixture model using numerical 
mixtures of two breast cancer cell line expressions. 
Sample/Tissue MCF7 (breast cancer)   HS27 (fibroblasts) 
  (assigned/estimated)     (assigned/estimated) 
Sample 1  0.4814/0.4771       0.5186/0.5229 
Sample 2  0.8432/0.8336       0.1568/0.1664 
Next, we tested our method on biologically mixed expressions 
from two breast cancer cell lines. The mRNA extracted from the in-
dividual cell lines are mixed with pre-specified proportions before 
subsequent procedures including amplification and microarray ex-
periment (Table 2). Such mixtures mimic the actual biological sam-
ples with varying relative abundances of the constituent subsets 
from one another (Fig. 2) (Kuhn, et al., 2011; Shen-Orr, et al., 2010). 
Table 2. Identification of linear mixture model using biological 
mixtures of two breast cancer cell line expressions. 
Sample/Tissue MCF7 (breast cancer)   HS27 (fibroblasts) 
  (assigned/estimated)     (assigned/estimated) 
Sample 1  0.75/0.7622       0.25/0.2378 
Sample 2  0.25/0.2424       0.75/0.7576 
The proposed method again accurately estimated the mixing propor-
tions with E1=0.0778 (and a correlation coefficient of 0.99) (Table 
2 and Fig. 2), and cell-specific expression patterns with an average 
correlation coefficient of 0.99 between the estimated expression 
profile of each type to the measured expression pattern in the pure 
cell line (Fig. 3). The high correlation that we achieved between the 
estimated proportions/tissue-expressions and ground truth suggests            
 
Figure 2. Scatter plot of biological mixing and blind model identification. 
that unsupervised deconvolution of tissue-specific expression pro-
files from two-source heterogeneous samples using a linear model 
should yield accurate expression estimates for most genes.  
 
Figure 3. Highly correlated scatter plots between the estimated and meas-
ured pure cell expression profiles (over ‘marker’ and ‘all’ genes). 
The theoretical roadmap also enables the extended detection of 
differentially-expressed genes beyond marker genes aimed at max-
imizing the information obtainable from mixed expressions. To as-
sess the specificity and sensitivity of detecting differentially ex-
pressed genes without deconvolution, we compared the ranked in-
dex subsets of differentially expressed genes between samples to a 
‘gold standard’ set of differentially expressed genes identified from 
the pure cell line measurements, on both numerical and biological 
mixtures of two breast cancer cell line expressions. In addition to 
the Venn diagram and Spearman’s rank correlation coefficient 
(rrank=0.92), receiver operating characteristics curve analysis 
showed that the detection of differentially expressed genes based on 
mixed expressions (Corollary 1) to be both highly specific and sen-
sitive with an area under the curve of 0.85 (supplementary infor-
mation).       
3.2 Analysis of benchmark expression data 
As an example for the purpose of comparison, we also analyzed the 
same public benchmark gene expression dataset (AFFY) used by 
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Ahn et al. (Ahn, et al., 2013). This dataset consists of biologically 
mixed heterogeneous samples with varying proportions of human 
brain and heart tissues. We selected 12 samples with brain/heart pro-
portion ratios of 0/100% (3 samples), 25%/75% (3 samples), 
75%/25% (3 samples) and 100%/0 (3 samples). In contrast to the 
semi-supervised methods that all require prior knowledge of gene 
expression of one tissue type (Ahn, et al., 2013; Clarke, et al., 2010; 
Gosink, et al., 2007), the 6 pure tissue samples were not used in any 
step of our proposed algorithm but simply served as the truth for 
assessment.  
For each proportion ratio, consistent with routine practice, we 
take the average of the 3 replicates (with the same proportion ratio) 
as the mixed/observed expression profile to be analyzed by the al-
gorithm. As aforementioned, in addition to accurate signal normali-
zation (Wang, et al., 2002), to maintain data quality and computa-
tional efficiency, we selected a subset of genes in the subsequent 
analyses by excluding minimally-expressed and outlier genes (sup-
plementary information) (Ahn, et al., 2013). This provided us with 
about 11000 probe sets across all samples.  
Table 3. Unsupervised estimation of unknown tissue proportions on 
AFFY brain-heart mixture dataset. 
Sample/Tissue Brain         Heart 
  (assigned/estimated)     (assigned/estimated) 
Sample 1  0.25/0.2342       0.75/0.7658 
Sample 2  0.75/0.7622       0.25/0.2378 
With pre-processed raw measured data, we first evaluated how 
well the proposed method estimated tissue proportions in this dataset 
(Table 3). Without using any knowledge of either tissue-specific ex-
pression or constituent proportions, as in other methods (Ahn, et al., 
2013; Clarke, et al., 2010; Gosink, et al., 2007; Kuhn, et al., 2011), 
our algorithm accurately estimated the unknown tissue proportions 
with a correlation coefficient of 0.99 (E1=0.1247), as compared with 
a correlation coefficient of 0.98 produced by the semi-supervised 
method on the same dataset (Fig. 4) (Ahn, et al., 2013).  
 
Figure 4. Scatter plot of brain-heart mixtures and proportion estimates. 
Next, we examined how well the proposed method estimated tis-
sue-specific expression patterns in this dataset. As shown in Fig. 5, 
the proposed method accurately and blindly estimated the gene ex-
pressions of pure brain and pure heart tissues, with a correlation co-
efficient of 0.96-0.99 between the estimated mean tissue expression 
levels and measured mean pure tissue expression levels, as compare 
to a correlation coefficient of 0.88-0.95 produced by the semi-super-
vised method on the same dataset. These results suggest that this 
unsupervised deconvolution method is able to accurately deconvo-
lute two-source mixed expressions (estimating both proportions and 
cell-specific profiles) from two or more heterogeneous samples. 
Detailed information on additional experimental results (tables, 
figures, datasets) are included in the supplementary information. 
4 DISCUSSION 
In this letter, we presented a feasible roadmap for unsupervised 
deconvolution of two-source mixed expressions, supported by the 
newly proved theorems under realistic conditions and experimental 
tests on real gene expression data. One important advantage of this 
unsupervised deconvolution approach lies in its unique and proven 
ability to detect cell-specific marker genes and estimate constituent 
proportions directly from mixed expressions when the relevant prior 
knowledge is either unreliable or unavailable. This is significant, in 
relation to semi-supervised methods, since it is well-known that (1) 
cell-specific marker genes (membership and expression) are condi-
tion-specific and (2) the total amount of mRNA from the same vol-
ume of cancer cells is much higher than that of normal cells (due to 
unknown tumor ploidy) (Clarke, et al., 2010).  
 
Figure 5. Estimation of tissue-specific gene expressions from AFFY: scatter 
plots comparing deconvolved mean brain/heart tissue expression values with 
measured mean pure brain/heart tissue expression values. 
We foresee a variety of extensions to the concepts and strategies 
in the proposed method. For example, with further development, in-
tratumor heterogeneity can be revealed in terms of hidden subclonal 
marker genes and subclonal repopulation dynamics.   
There is also a possible way to estimate the marker expression 
profiles for individual samples (Ahn, et al., 2013). Rewrite (1) as  
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where j is the tissue type index. According to (3), â1j and â2j are 
obtained via some form of ‘averaging’ over tissue-specific marker 
genes, where for each sample we may reasonably assume   
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Denote stissuej,samplek(iMGj)=stissuej(iMGj)+∆stissuej,samplek(i), we have 
tissue ,sample MG sample MG ,                  (8)( ) ( )j k j k j kjs i x i a=
  
for each of k and j, where k is the sample index.    
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